학술논문
First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)
Document Type
Journal
Author
Postel-Vinay, Sophie; Lam, Vincent K.; Ros, Willeke; Bauer, Todd M.; Hansen, Aaron R.; Cho, Daniel C.; Stephen Hodi, F.; Schellens, Jan H. M.; Litton, Jennifer K.; Aspeslagh, Sandrine; Autio, Karen A.; Opdam, Frans L.; McKean, Meredith; Somaiah, Neeta; Champiat, Stephane; Altan, Mehmet; Spreafico, Anna; Rahma, Osama; Paul, Elaine M.; Ahlers, Christoph M.; Zhou, Helen; Struemper, Herbert; Gorman, Shelby A.; Watmuff, Maura; Yablonski, Kaitlin M.; Yanamandra, Niranjan; Chisamore, Michael J.; Schmidt, Emmett, V; Hoos, Axel; Marabelle, Aurelien; Weber, Jeffrey S.; Heymach, John, V
Source
Subject
Language
English
ISSN
20511426